Increased sensitivity to the components of the drug; severely impaired liver function and/or liver function; congenital hyperbilirubinemia; deficiency of glucose-6-phosphate dehydrogenase; phenylketonuria, alcoholism; blood disease; leukopenia; anemia; severe forms of arrhythmia, arterial hypertension, atherosclerosis, ischemic heart disease; hyperthyroidism; gostria pancreatitis; prostate hypertrophy due to clogging; obstruction of the neck of the mikhur; piloroduodenal obstruction; bronchial asthma; postcutaneous glaucoma; pheochromocytoma; thrombosis; thrombophlebitis; blood diabetes; epilepsy; become an advanced awakening; sleep disturbance, concomitant treatment with tricyclic antidepressants, β-blockers, other sympathomimetics, drugs that suppress or increase appetite, and amphetamine-like psychostimulants; simultaneous bathing and 2 further treatments after stagnation of MAO inhibitors.
It is not possible to exceed the recommended doses. If the condition does not flare up for 5 days or is accompanied by a high temperature, lasting soreness for more than 3 days, a sore throat or a severe headache, please consult a doctor, splinters in the chest may be symptoms of b more than serious illness.
In connection with the risk of severe liver damage in case of overdose, do not immediately combine with other drugs for the symptomatic treatment of colds and the undead (vasoconstrictor, paracetamol). Use the drug with care in case of Raynaud's disease, arterial hypertension, heart disease, arrhythmia, bradycardia, thyroid disease, liver disease, acute hepatitis, glaucoma, chronic ailments of the lungs, prostate hypertrophy (fragments and a risk of shading), for people of summer age, with high blood pressure, hemolytic anemia, chronic malnutrition, anemia, stenosing peptic infection. The risk of hepatotoxicity advances especially with alcoholic liver damage and especially with alcohol abuse.
Before taking the drug, it is necessary to consult with a doctor if the liver or liver is sick; when taking warfarin or similar anticoagulants; take analgesics every day for mild arthritis; bronchial diseases (asthma, emphysema, chronic bronchitis).
The drug can be combined with blood glucose, sechoic acid, creatinine, and inorganic phosphates based on laboratory results. The result of testing collected blood in stool may be negative.
In patients with severe infections (sepsis), in which glutathione levels are reduced, the risk of metabolic acidosis increases when taking paracetamol. Symptoms of metabolic acidosis are severe, accelerated or difficult breathing, boredom, vomiting, loss of appetite. If these symptoms occur, it is important to contact a doctor.
It is not recommended to take this drug at the end of the day; ascorbic acid fragments in large doses provide a mild stimulant effect. In connection with the stimulating infusion of ascorbic acid on the release of corticosteroid hormones, control of the function of the nervous system and arterial pressure is required.
With particular caution, the drug should be prescribed to patients with impaired metabolic metabolism (hemosiderosis, hemochromatosis, thalassemia), with a history of nephrolithiasis (risk of hyperoxaluria and precipitation of oxalates in the urinary tract after taking large doses of ascorbic acid).
Sustaining large doses of ascorbic acid can accelerate its metabolism, which can lead to paradoxical hypovitaminosis after treatment. Do not combine the drug simultaneously with other drugs such as vitamin C. The absorption of ascorbic acid may be affected by impaired intestinal motility, enteritis, or decreased sputum secretion.
The drug contains phenylephrine, which can cause angina attacks.
Tartrazine (E 102) may cause allergic reactions.
If the patient has an intolerance to certain drugs, consult a doctor first and take this medication first.
This medicine should be administered at 1.26 mmol (or 28.9 mg)/dose of sodium (1 packet of medicine). Be careful when stagnant patients are on a sodium-controlled diet.
